ReviewDiscover nano2025

Microneedle-nanoparticle hybrid platforms for metabolic syndrome: advances in point-of-care diagnostics and transdermal therapeutics.

Jaewon Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.